ResMed Inc. (RMD)
NYSE: RMD · IEX Real-Time Price · USD
189.35
+2.41 (1.29%)
At close: Jul 2, 2024, 4:00 PM
190.73
+1.38 (0.73%)
After-hours: Jul 2, 2024, 7:46 PM EDT
ResMed Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for ResMed stock have an average target of 213.67, with a low estimate of 169 and a high estimate of 260. The average target predicts an increase of 12.84% from the current stock price of 189.35.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 5 | 5 | 5 | 5 | 4 |
| Hold | 3 | 3 | 3 | 3 | 3 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 25, 2024 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 24, 2024 |
| Needham | Needham | Strong Buy Reiterates $236 | Strong Buy | Reiterates | $236 | +24.64% | Jun 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $205 → $200 | Buy | Maintains | $205 → $200 | +5.62% | Apr 26, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $187 → $200 | Hold | Maintains | $187 → $200 | +5.62% | Apr 26, 2024 |
Financial Forecast
Revenue This Year
4.73B
from 4.22B
Increased by 11.89%
Revenue Next Year
5.07B
from 4.73B
Increased by 7.22%
EPS This Year
7.81
from 6.09
Increased by 28.23%
EPS Next Year
8.72
from 7.81
Increased by 11.66%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.0B | 5.4B | 5.9B | 6.5B | 7.1B |
| Avg | 4.7B | 5.1B | 5.4B | 5.9B | 6.3B |
| Low | 4.6B | 4.8B | 5.0B | 5.4B | 6.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.3% | 14.1% | 16.5% | 19.3% | 20.7% |
| Avg | 11.9% | 7.2% | 6.9% | 8.1% | 8.3% |
| Low | 7.8% | 1.4% | -1.0% | 0.2% | 2.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.28 | 9.75 | 11.01 | 11.70 | 13.04 |
| Avg | 7.81 | 8.72 | 9.59 | 10.38 | 11.57 |
| Low | 7.47 | 8.08 | 8.79 | 9.60 | 10.29 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 36.0% | 24.9% | 26.3% | 21.9% | 25.6% |
| Avg | 28.2% | 11.7% | 10.0% | 8.2% | 11.5% |
| Low | 22.6% | 3.5% | 0.8% | 0.1% | -0.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.